ACLF	Acute on chronic liver failure
ADAMTS13	A disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13
ADP	Adenosine diphosphate
AKI	Acute kidney injury
ALF	Acute liver failure
APC	Antigen-presenting cells
CPFA	Coupled plasma filtration adsorption
CRRT	Continuous renal replacement therapy
DAMP	Pathogen-associated molecular patterns
DIC	Disseminated intravascular coagulopathy
DNA	Deoxyribonucleic acid
EAA	Endotoxin activity assay
ECLS	Extracorporeal liver support
ECMO	Extracorporeal membrane oxygenation
FFP	Fresh frozen plasma
FPSA	Fractional plasma separation and adsorption
HCO	High cut-off
HE	Hepatic encephalopathy
HVHF	High-volume hemofiltration
ICU	Intensive care unit
IFN	Interferon
IL	Interleukin
IL-1ra	Interleukin-1 receptor antagonist
KDIGO	Kidney Disease Improving Global Outcomes
LPS	Lipopolysaccharide
MARS	Molecular adsorbent recirculating system
NET	Neutrophil extracellular traps
NF-κB	Nuclear factor-kappa-light-chain-enhancer of activated B cells
NOS	Newcastle–Ottawa scale
PAMP	Pathogen-associated molecular patterns
PEI	Polyethyleneimine
PMX	Polymyxin B-immobilized fiber columns
PRR	Pattern recognition receptor
RCT	Randomized clinical trial
SIC	Sepsis induced coagulopathy
SPAD	Single-pass albumin dialysis
SOFA	Sequential organ failure assessment
TAMOF	Thrombocytopenia-associated multiple organ failure
TF	Tissue factor
TFPI	Tissue factor pathway inhibitor
TLR	Toll-like receptor
TMA	Thrombocytopenic microangiopathy
TNF	Tumor necrosis factor
TPE	Therapeutic plasma exchange
TTP	Thrombotic thrombocytopenic purpura
VHVHF	Very-high-volume hemofiltration
vWF	von Willebrand factor
vWFCP	von Willebrand factor-cleaving protease